GALECTIN THERAPEUTICS INC — Director's Dealing 2011

Jul 19, 2011

SEC Form 4/A — Form 4/A

Issuer: GALECTIN THERAPEUTICS INC (GALT.OB)
CIK: 0001133416
Period of Report: 2011-06-02

Reporting Person: MAULDIN JOHN F (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-06-02	Employee Stock Option (right to buy)	$1.35	A	88.888	Acquired	2021-06-02	Common Stock (88888)	Direct

Footnotes

F1: The option vests quarterly in eight equal installments beginning September 2, 2011.

F2: This amended Form 4 corrects the exercise price (increase) and the number of shares (decrease) subject to the option so as to be consistent with the terms of the grant.